Clinical Trial Update: A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating treatment of inflammation before stem cell transplant in people with Primary Immune Regulatory Disorder or Autoimmune Lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Lymphoproliferative Syndrome
• Immune Regulatory Disorder

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative | Phase 2 | Status: RECRUITING